Transmission of hepatitis B virus 2 months prior to hepatitis surface antigen positivity of donor blood

被引:11
作者
Meisel, H
Endres, AS
Walter, HU
Wend, UC
Gerlich, WH
机构
[1] Univ Giessen, Inst Med Virol, Natl Consulting Lab Blood Transmitted Virus Infec, D-35392 Giessen, Germany
[2] Humboldt Univ, Charite, Inst Virol, Berlin, Germany
[3] Humboldt Univ, Charite, Clin Orthopedy, Berlin, Germany
关键词
nucleic acid amplification; HBV; real time PCR;
D O I
10.1159/000074288
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
An hepatitis surface antigen(HBsAg)-negative donation transmitted hepatitis B virus (HBV) of the very common genotype A/HBsAg subtype adw2 to the recipient of the erythrocyte concentrate. Two months later the donor became borderline HBsAg-positive. The infectious donation was tested retrospectively by real time PCR and contained approximately 2,000 viral genomes/ml, an amount which would have been well detectable by minipool nucleic acid amplification test (NAT) for HBV DNA at the usual detection limit of 1,000 copies/ml. The case shows that the HBsAg-negative, HBV DNA-positive phase may be longer than previously believed and that HBV DNA screening at a sensitivity achievable by minipool NAT testing would have prevented transmission.
引用
收藏
页码:228 / 231
页数:4
相关论文
共 22 条
[1]   Comparative sensitivity of HBVNATs and HBsAg assays for detection of acute HBV infection [J].
Biswas, R ;
Tabor, E ;
Hsia, CC ;
Wright, DJ ;
Laycock, ME ;
Fiebig, EW ;
Peddada, L ;
Smith, R ;
Schreiber, GB ;
Epstein, JS ;
Nemo, GJ ;
Busch, MP .
TRANSFUSION, 2003, 43 (06) :788-798
[2]  
BURGER R, 2003, BUNDESGESUNDHBL, V46, P160
[3]  
Busch MP, 2000, VOX SANG, V78, P253
[4]   Very low level viremia in HCV infectious unit missed by NAT [J].
Busch, MP ;
Tobler, LH ;
Gerlich, WH ;
Schaefer, S ;
Giachetti, C ;
Smith, R .
TRANSFUSION, 2003, 43 (08) :1173-1174
[5]   Evaluation of a new PCR assay with competitive internal control sequence for blood donor screening [J].
Drosten, C ;
Weber, M ;
Seifried, E ;
Roth, WK .
TRANSFUSION, 2000, 40 (06) :718-724
[6]   Quantitative detection of hepatitis B virus DNA in two international reference plasma preparations [J].
Heermann, KH ;
Gerlich, WH ;
Chudy, M ;
Schaefer, S ;
Thomssen, R .
JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (01) :68-73
[7]   The cost-effectiveness of NAT for HIV, HCV, and HBV in whole-blood donations [J].
Jackson, BR ;
Busch, MP ;
Stramer, SL ;
AuBuchon, JP .
TRANSFUSION, 2003, 43 (06) :721-729
[8]   Molecular approaches to validate disinfectants against human hepatitis B virus [J].
Jursch, CA ;
Gerlich, WH ;
Glebe, D ;
Schaefer, S ;
Marie, O ;
Thraenhart, O .
MEDICAL MICROBIOLOGY AND IMMUNOLOGY, 2002, 190 (04) :189-197
[9]   Subtypes, genotypes and molecular epidemiology of the hepatitis B virus as reflected by sequence variability of the S-gene [J].
Magnius, LO ;
Norder, H .
INTERVIROLOGY, 1995, 38 (1-2) :24-34
[10]   Superiority of minipool nucleic acid amplification technology for hepatitis B virus over chemiluminescence immunoassay for hepatitis B surface antigen screening [J].
Minegishi, K ;
Yoshikawa, A ;
Kishimoto, S ;
Yugi, H ;
Yokoya, N ;
Sakurada, M ;
Kiyokawa, H ;
Nishioka, K .
VOX SANGUINIS, 2003, 84 (04) :287-291